Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. - Wikidata - awgldk - TriplyDB

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.

http://www.wikidata.org/entity/Q34256132

about

NAFLD and Chronic Kidney Disease Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Liver fibrosis markers of nonalcoholic steatohepatitis.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining.Surgical treatment of nonalcoholic fatty liver disease in severely obese patients Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort Differential representation of liver proteins in obese human subjects suggests novel biomarkers and promising targets for drug development in obesity.Review and Recommendations for the Component Tests in the Liver Function Test Profile Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients.Fatty liver in childhood.Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease.Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism.New Era for Usage of Serum Liver Enzymes as A Promising Horizon for the Prediction of Non-Alcoholic Fatty Liver Disease.Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD.Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.

P2860

Q26752759-A1FC88DD-5782-4406-99DA-0C3973407937 Q26765175-085D00C1-0FD3-4DF1-9AA4-AD6D7518BB64 Q26800894-3978D7A2-B2AB-4A2F-93A9-BD87903BF3E0 Q26828855-94201B1C-9981-4F36-8C3A-7524DA0F118C Q27005988-2E79BD5E-0AD3-473E-B133-28FAEA49D13D Q28084035-8BDFEA75-0498-4034-B83D-72FD61D4C4DB Q30382278-97414607-F98B-42C4-9129-81700C39ED84 Q30407625-503ECD81-9C02-48F1-9010-BFEC254E0C79 Q30435948-E7E987DC-CB12-4A2C-B524-597A4D3F7787 Q30994991-2AAEA653-BCF6-430C-8358-241DFCB606D1 Q34446294-897EF2AA-1E9F-464C-9471-B7991773FD68 Q35715977-076EAFB5-5A7D-4D7E-8B8D-5BC1D7FA2543 Q36301141-F3F339D3-6129-4432-BD24-441260579D27 Q36515774-5C9452BF-87C6-4ED3-BEA1-82246E97C394 Q37028786-237AAA62-3072-481F-A718-F1227E837CA8 Q37636566-0FC123E0-DC9C-4984-8E2A-8EB916781FD2 Q37707621-C31FDB72-D2B7-4A24-8733-20D54A847C4E Q38430909-A54A2ECB-9BFC-4553-AEA9-29044E826349 Q38992755-034BD76E-E460-4D7D-9E92-3D14DCC4E748 Q41231178-64F6BEC0-1237-4568-91A4-E2CCCEE92874 Q42284206-CE6884A2-AA9A-44EE-B7CE-620EDE94A864 Q42674347-863D111A-37E4-4092-93C2-E11AAE707E5A Q43476077-69F621BB-C71B-4615-9547-C3C9FCC88F3E Q45305677-42DB1749-2CB2-4E1F-9D25-7CDD5E58B152 Q47150578-C3D0520B-9EF0-4CD1-B728-F34154B7889A Q47884913-10C99999-931E-4449-98DF-EEA6A0948553 Q48056257-C173350C-76B5-415F-8EDD-D99DB4E6091F

P2860

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.

http://www.wikidata.org/entity/Q34256132

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@ast

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@en

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@nl

type

label

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@ast

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@en

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@nl

prefLabel

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@ast

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@en

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@nl

P1433

Q34256132-3C65AABC-130E-45D5-A76A-5F3B15F5E961

P1476

Q34256132-4C0C8082-6042-440C-ABA7-C2EA9FD57243

P2093

Q34256132-355D74DE-0D15-4A4B-9C53-10A0042E2F93

Q34256132-4C5F110A-AC69-4383-A7F9-3035AA94E340

Q34256132-D180EFE5-9C02-46A7-B4A1-1E177D629C7C

P2860

Q34256132-00FD0F65-0A79-4DD2-9BC0-1C9B73C1059D

Q34256132-015E6934-DC73-47E6-8C13-95CA0BFD8162

Q34256132-05C2ED3E-BD5B-4F8B-AFB4-83499A7AFD5A

Q34256132-05EF0558-B6EC-49CA-8BC7-07696FB584C2

Q34256132-086AD28B-701E-42F4-BB2F-25D97F6B1830

Q34256132-14DF1953-E944-4205-87A7-278EE50ADCC9

Q34256132-16B85898-ACD4-4E9F-9E61-0F22A02A7C1F

Q34256132-16BABF10-F240-4173-9610-CB7ACD958FDD

Q34256132-18BB4419-CA53-4E2E-81A3-9E3C74AE4D45

Q34256132-1A4FDE82-E655-428D-B420-ECF6515D4D21

P2888

Q34256132-83C087B4-F2D0-4F6C-9D04-9FE9F18CC952

P304

Q34256132-A4F191D9-B244-4384-8CE6-7713F25D01F6

P31

Q34256132-7599FCC7-042C-42FC-A1DB-7A9E6ECFCDD9

P356

Q34256132-14281E7F-AD7D-4102-9FFE-E9FD45690D34

P433

Q34256132-0D2AFC36-D03F-4FE7-8062-B4EAF3BF700F

P478

Q34256132-3548D4B6-5017-4EF8-8E2A-A5082A65252C

P577

Q34256132-C581E4A1-5735-4262-A2F3-9386CDAFFDF4

P5875

Q34256132-D3B5796D-861C-42E4-94B1-929D68791E9B

P6179

Q34256132-1FA44CD2-CD8E-4251-8A04-4D65F8487714

P698

Q34256132-4455F393-86FD-4458-9DCB-85B198DD2718

P921

Q34256132-B7377D06-1420-4BEF-AF6F-37C0AB2DC6D8

Q34256132-CFB7629B-78ED-4423-AC3B-ED318888ADEE

P932

Q34256132-6ACCF55B-B38B-4566-8D09-BB848C06B0FD

P356

P1433

Biomarker Research

P1476

Noninvasive biomarkers for the ...... nd advanced fibrosis in NAFLD.

@en

P2093

Jen-Jung Pan

http://www.w3.org/2001/XMLSchema#string

Nirav C Thosani

http://www.w3.org/2001/XMLSchema#string

Steven G Pearce

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Liver fibrosis in overweight patients

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Nonalcoholic fatty liver disease

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

P2888

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2050-7771-1-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257885153

http://www.w3.org/2001/XMLSchema#string

P6179

1017400992

http://www.w3.org/2001/XMLSchema#string

P698

24252302

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

4177607

http://www.w3.org/2001/XMLSchema#string